Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial (CATT)

NCT00593450 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00593450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00593450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial (CATT)
Lead sponsor
University of Pennsylvania
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
April 30, 2015
Enrollment
1,208 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration